3.9500
+0.0700
+(1.80%)
At close: March 3 at 5:26:30 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
45,553
68,240
109,455
85,529
Total Liabilities Net Minority Interest
6,869
12,125
12,293
13,381
Total Equity Gross Minority Interest
38,684
56,115
97,162
72,148
Total Capitalization
38,684
56,115
97,162
72,148
Common Stock Equity
38,684
56,115
97,162
72,148
Capital Lease Obligations
1,374
2,601
3,647
2,310
Net Tangible Assets
38,684
56,115
97,162
72,148
Working Capital
21,087
32,912
61,620
33,187
Invested Capital
38,684
56,115
97,162
72,148
Tangible Book Value
38,684
56,115
97,162
72,148
Total Debt
1,374
2,601
3,647
2,310
Share Issued
49,038.5820
46,553.5110
46,553.5110
28,372.6340
Ordinary Shares Number
49,038.5820
46,553.5110
46,553.5110
28,372.6340
12/31/2020 - 7/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1VT.DU Viking Therapeutics Inc
24.59
-10.39%
1VT.SG Viking Therapeutics Inc
24.54
-11.89%
W2J.F Carisma Therapeutics, Inc.
0.3716
-1.80%
0M4.DU Mersana Therapeutics Inc
0.4683
-0.49%
W2J.SG CARISMA Therapeutics Inc
0.3740
-2.76%
0M4.F Mersana Therapeutics, Inc.
0.4229
-0.33%
0M4.BE Mersana Therapeutics Inc
0.4663
-1.71%
0M4.MU Mersana Therapeutics Inc
0.4915
0.00%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.83
+12.66%
OBD.L Oxford BioDynamics Plc
0.5150
-6.70%